Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Budney, A. J. Articles by Vandrey, R. Search for Related Content PubMed Citation Articles by Budney, A. J. Articles by Vandrey, R. Cannabis Symptoms/Dimensions

Review of the Validity and Significance of Cannabis Withdrawal Syndrome

The authors review the literature examining the validity and significance of cannabis withdrawal syndrome. Findings from animal laboratory research are briefly reviewed, and human laboratory and clinical studies are surveyed in more detail. Converging evidence from basic laboratory and clinical studies indicates that a withdrawal syndrome reliably follows discontinuation of chronic heavy use of cannabis or tetrahydrocannabinol. Common symptoms are primarily emotional and behavioral, although appetite change, weight loss, and physical discomfort are also frequently reported. The onset and time course of these symptoms appear similar to those of other substance withdrawal syndromes. The magnitude and severity of these symptoms appear substantial, and these findings suggest that the syndrome has clinical importance. Diagnostic criteria for cannabis withdrawal syndrome are proposed.

This article has been cited by other articles:

				A. Agrawal, M. L. Pergadia, S. F. Saccone, M. T. Lynskey, J. C. Wang, N. G. Martin, D. Statham, A. Henders, M. Campbell, R. Garcia, et al. An Autosomal Linkage Scan for Cannabis Use Disorders in the Nicotine Addiction Genetics Project Arch Gen Psychiatry, June 1, 2008; 65(6): 713 - 721. [Abstract] [Full Text] [PDF]

				S. Potvin, E. Kouassi, O. Lipp, R.-H. Bouchard, M.-A. Roy, M.-F. Demers, A. Gendron, G. Astarita, D. Piomelli, and E. Stip Endogenous cannabinoids in patients with schizophrenia and substance use disorder during quetiapine therapy J Psychopharmacol, May 1, 2008; 22(3): 262 - 269. [Abstract] [PDF]

				P. Papathanasopoulos, L. Messinis, E. Lyros, A. Kastellakis, and G. Panagis Multiple Sclerosis, Cannabinoids, and Cognition J Neuropsychiatry Clin Neurosci, February 1, 2008; 20(1): 36 - 51. [Abstract] [Full Text] [PDF]

				M. Accordino, C. L. Hart, L. Messinis, and P. Panagiotis Neuropsychological deficits in long-term frequent cannabis users Neurology, November 28, 2006; 67(10): 1902 - 1902. [Full Text] [PDF]

				P. D. Skosnik, G. P. Krishnan, E. E. Aydt, H. A. Kuhlenshmidt, and B. F. O'Donnell Psychophysiological Evidence of Altered Neural Synchronization in Cannabis Use: Relationship to Schizotypy Am J Psychiatry, October 1, 2006; 163(10): 1798 - 1805. [Abstract] [Full Text] [PDF]

				P A McArdle Cannabis use by children and young people. Arch. Dis. Child., August 1, 2006; 91(8): 692 - 695. [Abstract] [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2004 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us